
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nuclear factor erythroid 2–related factor 2 and β‐Catenin Coactivation in Hepatocellular Cancer: Biological and Therapeutic Implications
Junyan Tao, Yekaterina Krutsenko, Akshata Moghe, et al.
Hepatology (2021) Vol. 74, Iss. 2, pp. 741-759
Open Access | Times Cited: 42
Junyan Tao, Yekaterina Krutsenko, Akshata Moghe, et al.
Hepatology (2021) Vol. 74, Iss. 2, pp. 741-759
Open Access | Times Cited: 42
Showing 1-25 of 42 citing articles:
β-Catenin signaling in hepatocellular carcinoma
Chuanrui Xu, Zhong Xu, Yi Zhang, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 4
Open Access | Times Cited: 171
Chuanrui Xu, Zhong Xu, Yi Zhang, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 4
Open Access | Times Cited: 171
Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy
Pan Song, Zirui Gao, Yige Bao, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 57
Pan Song, Zirui Gao, Yige Bao, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 57
Hepatocellular carcinoma: signaling pathways and therapeutic advances
Jiaojiao Zheng, Siying Wang, Lei Xia, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Jiaojiao Zheng, Siying Wang, Lei Xia, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Cell type-specific regulation of the pentose phoshate pathway during development and metabolic stress-driven autoimmune diseases: Relevance for inflammatory liver, renal, endocrine, cardiovascular and neurobehavioral comorbidites, carcinogenesis, and aging
Katalin Bánki, András Perl
Autoimmunity Reviews (2025) Vol. 24, Iss. 5, pp. 103781-103781
Closed Access | Times Cited: 2
Katalin Bánki, András Perl
Autoimmunity Reviews (2025) Vol. 24, Iss. 5, pp. 103781-103781
Closed Access | Times Cited: 2
Oxidative Stress in Non-Alcoholic Fatty Liver Disease
Carlo Smirne, Eleonora Croce, Davide Di Benedetto, et al.
Livers (2022) Vol. 2, Iss. 1, pp. 30-76
Open Access | Times Cited: 45
Carlo Smirne, Eleonora Croce, Davide Di Benedetto, et al.
Livers (2022) Vol. 2, Iss. 1, pp. 30-76
Open Access | Times Cited: 45
WNT/β-catenin signaling in hepatocellular carcinoma: The aberrant activation, pathogenic roles, and therapeutic opportunities
Anna Gajos-Michniewicz, Małgorzata Czyż
Genes & Diseases (2023) Vol. 11, Iss. 2, pp. 727-746
Open Access | Times Cited: 32
Anna Gajos-Michniewicz, Małgorzata Czyż
Genes & Diseases (2023) Vol. 11, Iss. 2, pp. 727-746
Open Access | Times Cited: 32
Molecular and immune landscape of hepatocellular carcinoma to guide therapeutic decision-making
Renumathy Dhanasekaran, Hiroyuki Suzuki, L Lemaître, et al.
Hepatology (2023)
Closed Access | Times Cited: 25
Renumathy Dhanasekaran, Hiroyuki Suzuki, L Lemaître, et al.
Hepatology (2023)
Closed Access | Times Cited: 25
Wnt/β-catenin signaling pathway in liver biology and tumorigenesis
Shinji Matsumoto, Akira Kikuchi
In Vitro Cellular & Developmental Biology - Animal (2024) Vol. 60, Iss. 5, pp. 466-481
Closed Access | Times Cited: 8
Shinji Matsumoto, Akira Kikuchi
In Vitro Cellular & Developmental Biology - Animal (2024) Vol. 60, Iss. 5, pp. 466-481
Closed Access | Times Cited: 8
Oxidative stress in obesity-associated hepatocellular carcinoma: sources, signaling and therapeutic challenges
Manoja K. Brahma, Eduardo Hideo Gilglioni, Lang Zhou, et al.
Oncogene (2021) Vol. 40, Iss. 33, pp. 5155-5167
Open Access | Times Cited: 49
Manoja K. Brahma, Eduardo Hideo Gilglioni, Lang Zhou, et al.
Oncogene (2021) Vol. 40, Iss. 33, pp. 5155-5167
Open Access | Times Cited: 49
Resistance of Lenvatinib in Hepatocellular Carcinoma
Qiuran Xu, Dong‐Sheng Huang, Jinhui Guo, et al.
Current Cancer Drug Targets (2022) Vol. 22, Iss. 11, pp. 865-878
Closed Access | Times Cited: 27
Qiuran Xu, Dong‐Sheng Huang, Jinhui Guo, et al.
Current Cancer Drug Targets (2022) Vol. 22, Iss. 11, pp. 865-878
Closed Access | Times Cited: 27
Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomes
Vivek P. Chavda, Kelsee K. Zajac, Jenna Lynn Gunn, et al.
Cancer Reports (2023) Vol. 6, Iss. S1
Open Access | Times Cited: 16
Vivek P. Chavda, Kelsee K. Zajac, Jenna Lynn Gunn, et al.
Cancer Reports (2023) Vol. 6, Iss. S1
Open Access | Times Cited: 16
Glutamine metabolic reprogramming in hepatocellular carcinoma
Yanyan Ye, Bodong Yu, Hua Wang, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 13
Yanyan Ye, Bodong Yu, Hua Wang, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 13
Immunotherapy in liver cancer: overcoming the tolerogenic liver microenvironment
Yanju Liu, Hongyuan Yang, Tian Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Yanju Liu, Hongyuan Yang, Tian Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
MYC and MET cooperatively drive hepatocellular carcinoma with distinct molecular traits and vulnerabilities
Celia Sequera, Margherita Grattarola, Ágnes Holczbauer, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 11
Open Access | Times Cited: 22
Celia Sequera, Margherita Grattarola, Ágnes Holczbauer, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 11
Open Access | Times Cited: 22
Immunoediting of KEAP1-NRF2 mutant tumours is required to circumvent NRF2-mediated immune surveillance
Liam Baird, Masayuki Yamamoto
Redox Biology (2023) Vol. 67, pp. 102904-102904
Open Access | Times Cited: 11
Liam Baird, Masayuki Yamamoto
Redox Biology (2023) Vol. 67, pp. 102904-102904
Open Access | Times Cited: 11
Redox Control of the Dormant Cancer Cell Life Cycle
Bowen Li, Yi‐Chun Huang, Hui Ming, et al.
Cells (2021) Vol. 10, Iss. 10, pp. 2707-2707
Open Access | Times Cited: 25
Bowen Li, Yi‐Chun Huang, Hui Ming, et al.
Cells (2021) Vol. 10, Iss. 10, pp. 2707-2707
Open Access | Times Cited: 25
β-Catenin Activation in Hepatocellular Cancer: Implications in Biology and Therapy
Yekaterina Krutsenko, Aatur D. Singhi, Satdarshan P. Monga
Cancers (2021) Vol. 13, Iss. 8, pp. 1830-1830
Open Access | Times Cited: 24
Yekaterina Krutsenko, Aatur D. Singhi, Satdarshan P. Monga
Cancers (2021) Vol. 13, Iss. 8, pp. 1830-1830
Open Access | Times Cited: 24
Molecular Targets of Ferroptosis in Hepatocellular Carcinoma
Hao Liao, Juanyi Shi, Kai Wen, et al.
Journal of Hepatocellular Carcinoma (2021) Vol. Volume 8, pp. 985-996
Open Access | Times Cited: 24
Hao Liao, Juanyi Shi, Kai Wen, et al.
Journal of Hepatocellular Carcinoma (2021) Vol. Volume 8, pp. 985-996
Open Access | Times Cited: 24
Targeting Wnt-β-Catenin Signaling Pathway for Hepatocellular Carcinoma Nanomedicine
Anita K. Bakrania, Jeffrey C. To, Gang Zheng, et al.
Gastro Hep Advances (2023) Vol. 2, Iss. 7, pp. 948-963
Open Access | Times Cited: 8
Anita K. Bakrania, Jeffrey C. To, Gang Zheng, et al.
Gastro Hep Advances (2023) Vol. 2, Iss. 7, pp. 948-963
Open Access | Times Cited: 8
The Role of Ferroptosis in the Treatment and Drug Resistance of Hepatocellular Carcinoma
Siqi Zhao, Wubin Zheng, Chao Yu, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 13
Siqi Zhao, Wubin Zheng, Chao Yu, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 13
Mechanism of iron on the intestinal epithelium development in suckling piglets
Lanmei Yin, Yitong Zhang, Jun Li, et al.
Science China Life Sciences (2023) Vol. 66, Iss. 9, pp. 2070-2085
Closed Access | Times Cited: 7
Lanmei Yin, Yitong Zhang, Jun Li, et al.
Science China Life Sciences (2023) Vol. 66, Iss. 9, pp. 2070-2085
Closed Access | Times Cited: 7
UBE2O promotes hepatocellular carcinoma cell proliferation and invasion by regulating the AMPKα2/mTOR pathway
Zhan Shi, Runkun Liu, Qiliang Lu, et al.
International Journal of Medical Sciences (2021) Vol. 18, Iss. 16, pp. 3749-3758
Open Access | Times Cited: 16
Zhan Shi, Runkun Liu, Qiliang Lu, et al.
International Journal of Medical Sciences (2021) Vol. 18, Iss. 16, pp. 3749-3758
Open Access | Times Cited: 16
Nanoquercetin and Extracellular Vesicles as Potential Anticancer Therapeutics in Hepatocellular Carcinoma
Alok Raghav, Goo‐Bo Jeong
Cells (2024) Vol. 13, Iss. 7, pp. 638-638
Open Access | Times Cited: 2
Alok Raghav, Goo‐Bo Jeong
Cells (2024) Vol. 13, Iss. 7, pp. 638-638
Open Access | Times Cited: 2
Wingless/It/β-catenin signaling in liver metastasis from colorectal cancer: A focus on biological mechanisms and therapeutic opportunities
Federico Selvaggi, Teresa Catalano, Rossano Lattanzio, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 18, pp. 2764-2783
Open Access | Times Cited: 6
Federico Selvaggi, Teresa Catalano, Rossano Lattanzio, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 18, pp. 2764-2783
Open Access | Times Cited: 6
Canonical Wnt Signaling in the Pathology of Iron Overload-Induced Oxidative Stress and Age-Related Diseases
A Austin, Ashok Mandala, Milan R. Malhotra, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 9
A Austin, Ashok Mandala, Milan R. Malhotra, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 9